TP53 and leiomyoma: In one analysis referencing both the WHO and Stanford classifications, atypical leiomyoma, STUMP, and leiomyosarcoma demonstrated significantly higher frequencies of TP53 mutations and PTEN deletions than conventional leiomyoma and leiomyoma variants.